Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Pagliaro

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Haematologica|February 27, 2025
<i>Ex vivo</i> drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with <i>PICALM::MLLT10</i>Elena Mastrodicasa, Luca Pagliaro, Valentina Pierini, et al.
Blood|May 19, 2026
Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic LeukemiaAnna Montanaro, Gregorio Monica, Raffaella Zamponi, et al.
Hemasphere|March 11, 2024
<i>Myb</i> overexpression synergizes with the loss of <i>Pten</i> and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemiaAndré Almeida, Sara T'Sas, Luca Pagliaro, et al.
Cell Chemical Biology|May 11, 2020
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic LeukemiaMatteo Marchesini, Andrea Gherli, Anna Montanaro, et al.
Cell Death & Disease|June 17, 2022
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemiaAnna Montanaro, Samuel Kitara, Elisa Cerretani, et al.
Genes|June 26, 2025
Genetics of Darier's Disease: New Insights into Pathogenic MechanismsBarbara Moschella, Sabrina Busciglio, Enrico Ambrosini, et al.
Nature Communications|June 4, 2024
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AMLMatteo Marchesini, Andrea Gherli, Elisa Simoncini, et al.
Blood|March 6, 2026
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemiaDanika Di Giacomo, Petri Pölönen, Valentina Bardelli, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Haematologica|February 27, 2025
<i>Ex vivo</i> drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with <i>PICALM::MLLT10</i>Elena Mastrodicasa, Luca Pagliaro, Valentina Pierini, et al.
Blood|May 19, 2026
Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic LeukemiaAnna Montanaro, Gregorio Monica, Raffaella Zamponi, et al.
Hemasphere|March 11, 2024
<i>Myb</i> overexpression synergizes with the loss of <i>Pten</i> and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemiaAndré Almeida, Sara T'Sas, Luca Pagliaro, et al.
Cell Chemical Biology|May 11, 2020
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic LeukemiaMatteo Marchesini, Andrea Gherli, Anna Montanaro, et al.
Cell Death & Disease|June 17, 2022
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemiaAnna Montanaro, Samuel Kitara, Elisa Cerretani, et al.
Genes|June 26, 2025
Genetics of Darier's Disease: New Insights into Pathogenic MechanismsBarbara Moschella, Sabrina Busciglio, Enrico Ambrosini, et al.
Nature Communications|June 4, 2024
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AMLMatteo Marchesini, Andrea Gherli, Elisa Simoncini, et al.
Blood|March 6, 2026
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemiaDanika Di Giacomo, Petri Pölönen, Valentina Bardelli, et al.
Pageof 2